NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Antisense Technology


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Alnylam Presents New Pre-Clinical Data on RNAi Therapeutics at Oligonucleotides Therapeutics Society OTS Meeting
2009 NOV 16 ... Technology, AIDS, Acquired Immunodeficiency Syndrome, Alnylam Pharmaceuticals Inc., Antisense Technology, Biotechnology, Drug Development, Drug Discovery, Gene Therapy, Genetics, Genomics, HIV, ...
Subject: Alnylam Pharmaceuticals, Inc.
Price: $3.00
*
Altair Therapeutics Secures $17 Million Financing
2009 NOV 23 ... Research, Science, Chemicals, Chemistry, Technology, Allergies, Allergy Medicine, Antisense Technology, Asthma, Biopharmaceuticals, Biotechnology, Clinical Trial Research, Congenital Lobar ...
Subject: Altair Therapeutics
Price: $3.00
*
Bio-Path Holdings, Inc. Operations Update
2009 NOV 16 ... delivery technology can be applied both to double stranded (siRNA) and single stranded (antisense) nucleic acid compounds, with the potential to revolutionize the treatment of cancer and ...
Subject: Bio-Path Holdings, Inc.
Price: $3.00
*
Findings from N. Nakashima et al in antisense technology reported
2009 NOV 17 ... Great Clarendon St., Oxford OX2 6DP, England. Keywords: Japan, Sapporo, Antisense Technology, Biotechnology, Escherichia coli, Gene Therapy, Treatment. This article was ...
Subject: Antisense Technology
Price: $3.00
*
Hudson's Bay Company Taps QuantiSense to Improve Retail Analytics, Transition to Cost Method of Inventory Accounting
2009 NOV 25 ... Electronics, Finance, Financial, Guitar Center, Investing, Investment, Technology, Antisense Technology, Biotechnology, Gene Therapy, Treatment, QuantiSense. This article was ...
Subject: QuantiSense
Price: $3.00
*
Isis Reports Financial Results and Highlights for Third Quarter of 2009
2009 NOV 16 ... in patients with type 2 diabetes. Further, we and our partners have advanced a number of antisense drugs into development and into the clinic. As we approach the end of 2009, our ... the end of 2009, our financial position ensures that we can continue to advance our technology, discover and develop a significant number of promising new drugs, and capitalize on our ...
Subject: Isis Pharmaceuticals, Inc.
Price: $3.00
*
New antisense technology study findings have been published by scientists at University of Sydney
2009 NOV 16 ... Inc., 111 River St., Hoboken, NJ 07030, USA. Keywords: Australia, Sydney, Antisense Technology, Biotechnology, Gastroenterology, Gene Therapy, Genetics, Hepatology, Protein Encoding, ...
Subject: Antisense Technology
Price: $3.00
*
New findings reported from K. Qian and co-authors describe advances in antisense technology
2009 NOV 17 ... Chase, MD 20815-5817, USA. Keywords: People's Republic of China, Wuhan, Antisense Technology, Biotechnology, Endocrinology, Gene Therapy, Treatment. This article was ...
Subject: Antisense Technology
Price: $3.00
*
New leukemia study findings recently were reported by researchers at Akita University
2009 NOV 23 ... Suite 200, Washington, DC 20036, USA. Keywords: City:Hondo, Country:Japan, Antisense Technology, Biotechnology, Gene Therapy, Genetics, Genomics, Hematology, Leukemia, Lymphoma, ...
Subject: Leukemia
Price: $3.00
*
Quark Pharmaceuticals to Present Data on its siRNA Therapeutic Programs in Kidney and Lung Diseases
2009 NOV 16 ... Both studies are scheduled to be completed this year. Keywords: Antisense Technology, Biotechnology, Clinical Trial Research, Gene Therapy, Genetics, Genomics, Infectious ...
Subject: Pharmaceuticals
Price: $3.00
*
Reports summarize vascular endothelial growth factor research from B. Cohen and co-authors
2009 NOV 16 ... Ann Arbor, MI 48109-0648, USA. Keywords: Israel, Rehovot, Angiogenesis, Antisense Technology, Biotechnology, Gene Therapy, Glioma, Lung Cancer, Neoplasia, Non-Small-Cell Lung ...
Subject: Vascular Endothelial Growth Factor
Price: $3.00
*
Research on biological chemistry described by scientists at Oregon Health & Science University, Medical Department
2009 NOV 27 ... Country:United States, City:Portland, State:OR, Country:United States, Life Sciences, Antisense Technology, Gene Therapy, Treatment, Biotechnology, Convertase, Enzymes, Protease, Biological ...
Subject: Biological Chemistry
Price: $3.00
*
Research on RNA research reported by scientists at Innsbruck Medical University
2009 NOV 12 ... Blvd., Woodbury, NY 11797-2924, USA. Keywords: Austria, Innsbruck, Antisense Technology, Biotechnology, Gene Therapy, RNA Research, Treatment, Innsbruck Medical University. ...
Subject: RNA Research
Price: $3.00
*
Researchers at University of California target antisense technology
2009 NOV 23 ... USA. Keywords: City:Los Angeles, State:CA, Country:United States, Antisense Technology, Biotechnology, Duchenne Muscular Dystrophy, Gene Therapy, Genetics, Muscular ...
Subject: Antisense Technology
Price: $3.00
*
Studies from K.S. Shavkunov et al in the area of nucleic acids research described
2009 NOV 17 ... Clarendon St., Oxford OX2 6DP, England. Keywords: Russia, Life Sciences, Antisense Technology, Gene Therapy, Treatment, Biotechnology, Escherichia coli, Polymerase, Enzymes, Nucleic ...
Subject: Nucleic Acids Research
Price: $3.00
*
Study findings from University of Connecticut provide new insights into virology
2009 NOV 16 ... Dr., Manhasset, NY 11030, USA. Keywords: United States, Farmington, Antisense Technology, Biotechnology, DNA, DNA Replication, DNA Research, Gene Therapy, Medical Device, ...
Subject: Virology
Price: $3.00
*
Study findings from University of Strasbourg provide new insights into antisense technology
2009 NOV 16 ... 6, London WC1X 8HL, England. Keywords: France, Illkirch-Graffenstaden, Antisense Technology, Biotechnology, Central Nervous System Disease, Drug Development, Drug Discovery, ...
Subject: Antisense Technology
Price: $3.00
*
Study findings on antisense technology are outlined in reports from University of Heidelberg
2009 NOV 16 ... St., Philadelphia, PA 19106-3621, USA. Keywords: Germany, Heidelberg, Antisense Technology, Arteriosclerosis, Atherosclerosis, Biotechnology, Cardiology, Dismutase, Drugs, ...
Subject: Antisense Technology
Price: $3.00
*
University of Heidelberg describes research in breast cancer therapy
2009 NOV 16 ... OX2 6DP, England. Keywords: Germany, Breast Cancer Therapy, Adriamycin, Antisense Technology, Apoptosis, Biotechnology, Breast Cancer, Breast Carcinoma, Breast Tumors, Chemotherapy, ...
Subject: Breast Cancer Therapy
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login